The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

BACKGROUND: Fibrates correct the typical lipid abnormalities of type 2 diabetes mellitus, yet no study, to date, has specifically set out to evaluate the role of fibrate therapy in preventing cardiovascular events in this setting. METHODS: Subjects with type 2 diabetes, aged 50–75 years, were screen...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1129022/
https://www.ncbi.nlm.nih.gov/pubmed/15571637
http://dx.doi.org/10.1186/1475-2840-3-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1129022/
https://www.ncbi.nlm.nih.gov/pubmed/15571637
http://dx.doi.org/10.1186/1475-2840-3-9

Ejemplares similares